Patient data and prognostic factors in 145 noncensored patients with HGA
| Prognostic Factor | No. | Survival (median) (95% CI) |
|---|---|---|
| Agea | ||
| <50 years | 21 | 330 (34–975) |
| ≥50 years | 124 | 178 (39–927) |
| Sex | ||
| Men | 89 | 175 (41–924) |
| Women | 56 | 201 (40–954) |
| WHO gradeb | ||
| Anaplastic astrocytoma (III) | 27 | 254 (43–963) |
| Glioblastoma (IV) | 118 | 178 (39–937) |
| Karnofsky Performance Statusa | ||
| <70 | 46 | 108 (39–472) |
| 70–80 | 56 | 197 (59–887) |
| >80 | 43 | 278 (57–1238) |
| Extent of surgeryb | ||
| Biopsy | 56 | 137 (28–849) |
| Partial resection | 53 | 197 (54–839) |
| Complete resection | 36 | 363 (63–1265) |
| Treatmentb | ||
| Conservative support | 55 | 92 (28–249) |
| Radiotherapy | 27 | 222 (94–461) |
| Chemoradiotherapy | 63 | 330 (109–1154) |
a No significant differences were found when only the noncensored patients were evaluated, but the differences reached significance level when the censored patients were included in the survival analysis.
b Significant differences were found with the logrank test.